Acetaminophen-induced liver injury in obesity and nonalcoholic fatty liver disease

被引:126
作者
Michaut, Anais [1 ]
Moreau, Caroline [1 ,2 ]
Robin, Marie-Anne [1 ]
Fromenty, Bernard [1 ]
机构
[1] Univ Rennes 1, INSERM, U991, Rennes, France
[2] CHU Pontchaillou, Lab Biochim & Toxicol, Rennes, France
关键词
acetaminophen; hepatotoxicity; obesity; fatty liver; steatosis; cytochrome P450 2E1; PARTIAL LEPTIN DEFICIENCY; DIABETIC KK-A(Y) MICE; DIET-INDUCED OBESITY; CYTOCHROME-P450; 2E1; INSULIN-RESISTANCE; METABOLIC SYNDROME; UNITED-STATES; OB/OB MICE; UDP-GLUCURONOSYLTRANSFERASE; INDUCED HEPATOTOXICITY;
D O I
10.1111/liv.12514
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Although acetaminophen (APAP) is usually considered as a safe drug, this painkiller can lead to acute liver failure after overdoses. Moreover, there is evidence that the maximum recommended dosage can induce hepatic cytolysis in some individuals. Several predisposing factors appear to enhance the risk and severity of APAP-induced liver injury including chronic alcoholic liver disease and nonalcoholic fatty liver disease (NAFLD), which refers to a large spectrum of hepatic lesions linked to obesity. In contrast, obesity by itself does not seem to be associated with a higher risk of APAP-induced liver injury. Since 1987, seven studies dealt with APAP-induced hepatotoxicity in rodent models of NAFLD and five of them found that this liver disease was associated with higher APAP toxicity. Unfortunately, these studies did not unequivocally established the mechanism(s) whereby NAFLD could favour APAP hepatotoxicity, although some investigations suggested that pre-existent induction of hepatic cytochrome P450 2E1 (CYP2E1) could play a significant role by increasing the generation of N-acetyl-p-benzoquinone imine (NAPQI), the toxic metabolite of APAP. Moreover, pre-existent mitochondrial dysfunction associated with NAFLD could also be involved. In contrast, some investigations suggested that factors that could reduce the risk and severity of APAP hepatotoxicity in obesity and NAFLD include higher hepatic APAP glucuronidation, reduced CYP3A4 activity and increased volume of body distribution. Thus, the occurrence and the outcome of APAP-induced liver injury in an obese individual with NAFLD might depend on a delicate balance between metabolic factors that can be protective and others that favour large hepatic levels of NAPQI.
引用
收藏
页码:E171 / E179
页数:9
相关论文
共 110 条
[1]   Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis [J].
Abdelmegeed, Mohamed A. ;
Banerjee, Atrayee ;
Yoo, Seong-Ho ;
Jang, Sehwan ;
Gonzalez, Frank J. ;
Song, Byoung-Joon .
JOURNAL OF HEPATOLOGY, 2012, 57 (04) :860-866
[2]  
ABERNETHY DR, 1983, J LAB CLIN MED, V101, P873
[3]   OBESITY, SEX, AND ACETAMINOPHEN DISPOSITION [J].
ABERNETHY, DR ;
DIVOLL, M ;
GREENBLATT, DJ ;
AMEER, B .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (06) :783-790
[4]   Induction of Vesicular Steatosis by Amiodarone and Tetracycline Is Associated with Up-regulation of Lipogenic Genes in HepaRG Cells [J].
Antherieu, Sebastien ;
Rogue, Alexandra ;
Fromenty, Bernard ;
Guillouzo, Andre ;
Robin, Marie-Anne .
HEPATOLOGY, 2011, 53 (06) :1895-1905
[5]   Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital [J].
Antoine, Daniel J. ;
Dear, James W. ;
Lewis, Philip Starkey ;
Platt, Vivien ;
Coyle, Judy ;
Masson, Moyra ;
Thanacoody, Ruben H. ;
Gray, Alasdair J. ;
Webb, David J. ;
Moggs, Jonathan G. ;
Bateman, D. Nicholas ;
Goldring, Christopher E. ;
Park, B. Kevin .
HEPATOLOGY, 2013, 58 (02) :777-787
[6]   Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: Mechanisms and pathophysiological role [J].
Aubert, J. ;
Begriche, K. ;
Knockaert, L. ;
Robin, M. A. ;
Fromenty, B. .
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2011, 35 (10) :630-637
[7]   Differences in Early Acetaminophen Hepatotoxicity between Obese ob/ob and db/db Mice [J].
Aubert, Jacinthe ;
Begriche, Karima ;
Delannoy, Matthieu ;
Morel, Isabelle ;
Pajaud, Julie ;
Ribault, Catherine ;
Lepage, Sylvie ;
McGill, Mitchell R. ;
Lucas-Clerc, Catherine ;
Turlin, Bruno ;
Robin, Marie-Anne ;
Jaeschke, Hartmut ;
Fromenty, Bernard .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2012, 342 (03) :676-687
[8]   Acetaminophen Pharmacokinetics in Children With Nonalcoholic Fatty Liver Disease [J].
Barshop, Nicole J. ;
Capparelli, Edmund V. ;
Sirlin, Claude B. ;
Schwimmer, Jeffrey B. ;
Lavine, Joel E. .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2011, 52 (02) :198-202
[9]   β-aminoisobutyric acid prevents diet-induced obesity in mice with partial leptin deficiency [J].
Begriche, Karima ;
Massart, Julie ;
Abbey-Toby, Adje ;
Igoudjil, Anissa ;
Letteon, Philippe ;
Fromenty, Bernard .
OBESITY, 2008, 16 (09) :2053-2067
[10]   Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice [J].
Begriche, Karima ;
Letteron, Philippe ;
Abbey-Toby, Adje ;
Vadrot, Nathalie ;
Robin, Marie-Anne ;
Bado, Andre ;
Pessayre, Dominique ;
Fromenty, Bernard .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2008, 294 (05) :E939-E951